However, some mutations were only found in patients with residual tumours (NOTCH4, NSD3, BPTF, PIK3CA, ASXL1, IGF1R, JAK1, ROS1, MYO3A, FLT4) (Figure 3). Here, MYO3A is linked to neoplasm.